FDA Approves Journavx Drug to Treat Pain Without Addiction Risk
The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive.
31 Jan 00:12 · NY Times
FDA Approves the First Non-Opioid Pain Drug in 20 Years
Experts see suzetrigine's potential in treating acute pain without the risk of addiction.
30 Jan 23:58 · TIME
FDA approves painkiller designed to eliminate risk of addiction
Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and OxyContin. The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals' Journavx for short-term pain...
31 Jan 02:30 · Voice of America
FDA approves painkiller designed to eliminate the risk of addiction associated with opioids
It’s the first new pharmaceutical approach to treating pain in more than 20 years, offering an alternative to both opioids and over-the-counter medications.
30 Jan 15:16 · The Seattle Times
last updated on 31 Jan 06:14